Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)
Open-label memantine in fragile X syndrome.
Journal of Autism and Developmental Disorders
39(12), pp. 1629-1635.
Erickson C. A. et al. (2014)
STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.
Journal of Autism and Developmental Disorders
44(4), pp. 958-964.
Fitzpatrick S. E. et al. (2016)
Aggression in autism spectrum disorder: presentation and treatment options.
Neuropsychiatric Disease and Treatment
2016(12), pp. 1525-1538
Kowalski J. et al. (2011)
Paliperidone palmitate in a child with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
October, 21(5), pp. 491-493
McGuire K. et al. (2015)
Journal of the American Academy of Child and Adolescent Psychiatry
December, 54(12), pp. 969-971.
Nikolov R. N. et al. (2009)
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
Journal of Autism and Developmental Disorders
39(3), pp. 405-413
Orsagh-Yentis D. K. et al. (2011)
Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified
Journal of Child and Adolescent Psychopharmacology
Posey D. J. et al. (2008)
Antipsychotics in the treatment of autism.
Journal of Clinical Investigation
118(1), pp. 6-14
Posey D. J. , Erickson C. A. , McDougle C. J. (2008)
Developing drugs for core social and communication impairment in autism.
Child and Adolescent Psychiatric Clinics of North America
17(4), pp. 787-801
Posey D. J. et al. (2006)
The use of selective serotonin reuptake inhibitors in autism and related disorders.
Journal of Child and Adolescent Psychopharmacology
16(1), pp. 181-186
Stigler K. A. et al. (2010)
Paliperidone for irritability in autistic disorder.
Journal of Child and Adolescent Psychopharmacology
pp. 75-78
Wink L. K. et al. (2017)
d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Molecular Autism
Wink L. K. et al. (2010)
Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.
Expert Opinion on Emerging Drugs
September, 15(3), pp. 481-494
Wink L. K. , Erickson C. A. , McDougle C. J. (2010)
Current Treatment Options in Neurology
12(6), pp. 529-538.